Dr. Changxing Lyu has nearly 40 years of clinical and research experience in radiation therapy for malignant tumors. He is widely recognized as a leading expert in thoracic tumor radiotherapy in China, with deep expertise in precision radiation treatment and comprehensive management of thoracic malignancies. He completed advanced training at the U.S. National Institutes of Health (NIH) and MD Anderson Cancer Center, gaining extensive experience in radiotherapy for tumors across all anatomical sites.
Dr. Lyu has published more than 30 papers in major domestic and international academic journals, including the International Journal of Cancer, Journal of Thoracic Oncology, and the Chinese Journal of Radiation Oncology, with over 10 SCI-indexed articles. He has served as chief editor or co-editor of more than ten professional monographs such as New Radiotherapy and Radiation Oncology. As a principal investigator, he has led research projects funded by the Shanghai Municipal Health Bureau and the National “11th Five-Year” Support Program, contributing significantly to the progress of cancer radiotherapy in China.
